SPIRIT 1: Efficacy and Safety Study of Relugolix in Women With Endometriosis-Associated Pain

NCT03204318 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

638

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometriosis Related Pain

Interventions

DRUG: Relugolix
DRUG: Estradiol/norethindrone acetate
DRUG: Estradiol/norethindrone acetate placebo
DRUG: Relugolix placebo

Sponsor

Myovant Sciences GmbH